Contribution of Nitric Oxide to the Apoptotic Process in Human B Cell Chronic Lymphocytic Leukaemia

References

• Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet J L, The French Cooperative Group on C. L. L. B-cell chronic lymphocytic leukemia: present status and future directions. Blood 1991; 78: 1901–1914
   PubMed Web of Science ®Google Scholar
• Foon K A, Rai K R, Gale R P. Chronic lymphocytic leukemia: new insights into biology and therapy. Ann Intern Med 1990; 113: 525–539
   PubMed Web of Science ®Google Scholar
• Durrieu F, Belloc F, Lacoste L, Dumain P, Chabrol J, Dachary-Prigent J, Morjani H, Boisseau M R, Reiffers J, Bernard P, Lacombe F. Caspase activation is an early event in anthra-cycline-induced apoptosis and allows detection of apoptotic cells before they are ingested by phagocytes. Exp Cell Res 1998; 240: 165–175
   PubMed Web of Science ®Google Scholar
• Mainou-Fowler T, Prentice A G. Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia. Leukemia & Lymphoma 1996; 21: 369–377
   PubMed Web of Science ®Google Scholar
• Mainou-Fowler T, Copplestone J A, Prentice A G. Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells. J Clin Pathol 1995; 48: 482–487
   PubMed Web of Science ®Google Scholar
• Chaouchi N, Wallon C, Goujard C, Tertian G, Rudent A, Caput D, Ferrera P, Minty A, Vazquez A, Delfraissy J F. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood 1996; 87: 1022–1029
   PubMed Web of Science ®Google Scholar
• Panayiotidis P, Ganeshaguru K, Jabbar S A, Hoffbrand A V. Alpha-interferon (alpha-IFN) protects B-chronic lymphocytic leukaemia cells from apoptotic cell death in vitro. Brit J Haematol 1994; 86: 169–173
   PubMed Web of Science ®Google Scholar
• Buschle M, Campana D, Carding S R, Richard C, Hoffbrand A V, Brenner M K. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med 1993; 177: 213–218
   PubMed Web of Science ®Google Scholar
• Panayiotidis P, Jones D, Ganeshaguru K, Foroni L, Hoffbrand A V. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol 1996; 92: 97–103
   PubMed Web of Science ®Google Scholar
• Lagneaux L, Delforge A, Bron D, De Bruyn C, Stryckmans P. Chronic lymphocytic leukemia B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood 1998; 91: 2387–2396
   PubMed Web of Science ®Google Scholar
• Fournier S, Delespesse G, Rubio M, Biron G, Sarfati M. CD23 antigen regulation and signaling in chronic lymphocytic leukemia. J Clin Invest 1992; 89: 1312–1321
   PubMed Web of Science ®Google Scholar
• Brizard A, Morel F, Lecron J C, Dreyfus B, Brízard F, Barra A, Preud'homme J L. Proliferative response of B chronic lymphocytic leukemia lymphocytes stimulated with IL2 and soluble CD23. Leukemia & Lymphoma 1994; 14: 311–318
   PubMed Web of Science ®Google Scholar
• Liu Y J, Cairns J A, Holder M J, Abbot S D, Jansen K U, Bonnefoy J Y, Gordon J, MacLennan I C. Recombinant 25-kDa CD23 and interleukin 1 alpha promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 1991; 21: 1107–1114
   PubMed Web of Science ®Google Scholar
• Reinisch W, Willheim M, Hilgarth M, Gasche C, Mader R, Szepfalusi S, Steger G, Berger R, Lechner K, Boltz-Nitulescu G, et al. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia. J Clin Oncol 1994; 12: 2146–2152
   PubMed Web of Science ®Google Scholar
• Sarfati M, Chevret S, Chastang C, Biron G, Stryckmans P, Delespesse G, Binet J L, Merle-Beral H, Bron D. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood 1996; 88: 4259–4264
   PubMed Web of Science ®Google Scholar
• Juliusson G J, Merup M. Cytogenetics in chronic lymphocytic leukemia. Semin Oncol 1998; 25: 19–26
   PubMed Web of Science ®Google Scholar
• Reed J C. Molecular biology of chronic lymphocytic leukemia. Semin Oncol 1998; 25: 11–18
   PubMed Web of Science ®Google Scholar
• Keating M J. Chronic lymphocytic leukemia. Semin Oncol 1999; 26: 107–114
   PubMed Web of Science ®Google Scholar
• Gottardi D, Alfarano A, De Leo A M, Stacchini A, Aragno M, Rigo A, Veneri D, Zanotti R, Pizzolo G, Caligaris-Cappio F. In leukaemic CD5+ B cells the expression of BCL-2 gene family is shifted toward protection from apoptosis. Br J Haematol 1996; 94: 612–618
   PubMed Web of Science ®Google Scholar
• Kitada S, Andersen J, Akar S, Zapata J M, Takayama S, Krajewski S, Wang H G, Zhang X, Bullrich F, Croce C M, Rai K, Hines J, Reed J C. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 1998; 91: 3379–3389
   PubMed Web of Science ®Google Scholar
• Genaro A M, Hortelano S, Alvarez A, Martinez C, Bosca L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 1995; 95: 1884–1890
   PubMed Web of Science ®Google Scholar
• Hortelano S, Bosca L. 6-Mercaptopurine decreases the Bcl-2/Bax ratio and induces apoptosis in activated splenic B lymphocytes. Mol Pharmacol 1997; 51: 414–421
   PubMed Web of Science ®Google Scholar
• Zhao H, Dugas N, Mathiot C, Delmer A, Dugas B, Sigaux F, Kolb J P. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. Blood 1998; 92: 1031–1043
   PubMed Web of Science ®Google Scholar
• Dugas B, Mossalayi D M, Damais C, Kolb J P. Nitric oxide production by human monocytes. Evidence for a role of CD23. Immunology Today 1995; 16: 574–580
   PubMedGoogle Scholar
• Mateo V, Lagneaux L, Bron D, Biron G, Armant M, Delespesse G, Sarfati M. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia. Nat Med 1999; 5: 1277–1284
   PubMed Web of Science ®Google Scholar
• Kroemer G, Zamzami N, Susin S A. Mitochondrial control of apoptosis. Immunology Today 1997; 18: 44–51
   PubMedGoogle Scholar
• Vermes I, Haanen C, Richel D J, Schaafsma M R, Kalsbeek-Batenburg E, Reutelingsperger C P. Apoptosis and secondary necrosis of lymphocytes in culture. Haematol 1997; 98: 8–13
   Web of Science ®Google Scholar
• Hermann P, Armant M, Brown E, Rubio M, Ishihara H, Ulrich D, Caspary R G, Lindberg F P, Armitage R, Maliszewski C, Delespesse G, Sarfati M. The vitronectin receptor and its associated CD47 molecule mediates proinflammatory cytokine synthesis in human monocytes by interaction with soluble CD23. J Cell Biol 1999; 144: 767–775
   PubMed Web of Science ®Google Scholar
• Fremeaux-Bacchi V, Aubry J P, Bonnefoy J Y, Kazatchkine M D, Kolb J P, Fischer E M. Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23. Eur J Immunol 1998; 28: 4268–4274
   PubMed Web of Science ®Google Scholar
• Fremeaux-Bacchi V, Kolb J P, Rakotobe S, Kazatchkine M D, Fischer E M. Functional properties of soluble CD21. Immunopharmacology 1999; 42: 31–37
   PubMed Web of Science ®Google Scholar
• Fremeaux-Bacchi V, Fischer E, Lecoanet-Henchoz S, Mani J C, Bonnefoy J Y, Kazatchkine M D. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells. Int Immunol 1998; 10: 1459–1466
   PubMed Web of Science ®Google Scholar
• Younes A, Snell V, Consoli U, Clodi K, Zhao S, Palmer J L, Thomas E K, Armitage R J, Andreeff M. Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukaemia. Br J Haematol 1998; 100: 135–141
   PubMed Web of Science ®Google Scholar
• Romano M F, Lamberti A, Tassone P, Alfinito F, Costantini S, Chiurazzi F, Defrance T, Bonelli P, Tuccillo F, Turco M C, Venuta S. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells. Blood 1998; 92: 990–995
   PubMed Web of Science ®Google Scholar
• Imaizumi K, Kawabe T, Ichiyama S, Kikutani H, Yagita H, Shimokata K, Hasegawa Y. Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction. Am J Physiol 1999; 277: L49–57
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Zeiher A M. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1997; 1: 275–281
   PubMed Web of Science ®Google Scholar
• Brune B, von Knethen A, Sandau K B. Nitric oxide and its role in apoptosis. Eur J Pharmacol 1998; 351: 261–272
   PubMed Web of Science ®Google Scholar
• Briine B, von Knethen A, Sandau K B. Nitric oxide (NO): an effector of apoptosis. Cell Death Differentiation 1999; 6: 969–975
   PubMed Web of Science ®Google Scholar
• Rossig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher A MM, Isch A, Dimmeler S. Nitric Oxide Inhibits Caspase-3 by S-Nitrosation in Vivo. J Biol Chem 1999; 274: 6823–6826
   PubMed Web of Science ®Google Scholar
• Krajewski S, Gascoyne R D, Zapata J M, Krajewska M, Kitada S, Chhanabhai M, Horsman D, Berean K, Piro L D, Fugier-Vivier I, Liu Y J, Wang H G, Reed J C. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes. Blood 1997; 89: 3817–3825
   PubMed Web of Science ®Google Scholar
• King D, Pringle J H, Hutchinson M, Cohen G M. Processing/activation of caspases, -3 and -7 and -8 but not caspase-2, in the induction of apoptosis in B-chronic lymphocytic leukemia cells. Leukemia 1998; 12: 1553–1560
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Haendeler J, Sause A, Zeiher A M. Nitric oxide inhibits APO-1/Fas-mediated cell death. Cell Growth Differ 1998; 9: 415–422
   PubMedGoogle Scholar
• Mannick J B, Miao X Q, Stamler J S. Nitric oxide inhibits Fas-induced apoptosis. J Biol Chem 1997; 272: 24125–24128
   PubMed Web of Science ®Google Scholar
• Mannick J B, Hausladen A, Liu L, Hess D T, Zeng M, Miao Q X, Kane L S, Gow A J, Stamler J S. Fas-induced caspase denitrosylation. Science 1999; 284: 651–654
   PubMed Web of Science ®Google Scholar
• Kim Y M, de Vera M E, Watkins S C, Billiar T R. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 1997; 272: 1402–1411
   PubMed Web of Science ®Google Scholar
• Sciorati C, Rovere P, Ferrarini M, Heltai S, Manfredi A A, Clementi E. Autocrine nitric oxide modulates CD95-induced apoptosis in gammadelta T lymphocytes. J Biol Chem 1997; 272: 23211–23215
   PubMed Web of Science ®Google Scholar
• Liu L, Stamler J S. NO: an inhibitor of cell death. Cell Death and Differentiation 1999; 6: 937–942
   PubMed Web of Science ®Google Scholar
• Levesque M C, Adams D J, Misukonis M A, Flowers J, Silber R, Weinberg J B. Detection of inducible nitric oxide synthase (NOSé) mRNA, antigen and enzyme activity in leukemia cells from patients with CLL. The Biology of Nitric Oxide. VI, S Moncada, 1999, In press
   Google Scholar
• Sonoki T, Matsuzaki H, Nagasaki A, Hata H, Yoshida M, Matsuoka M, Kuribayashi N, Kimura T, Harada N, Takatsuki K, Mitsuya H, Mori M. Detection of inducible nitric oxide synthase (iNOS) mRNA by RT-PCR in ATL patients and HTLV-I infected cell lines: clinical features and apoptosis by NOS inhibitor. Leukemia 1999; 13: 713–718
   PubMed Web of Science ®Google Scholar
• Mannick J B, Asano K, Izumi K, Kieff E, Stamler J S. Nitric oxide produced by human lymphocytes inhibit apoptosis and Epstein-Barr virus reactivation. Cell 1994; 79: 1137–1146
   PubMed Web of Science ®Google Scholar
• Eigler A, Waller-Fontaine K, Moeller J, Hartmann G, Hacker U T, Endres S. The hairy cell leukemia cell line Eskol spontaneously synthesizes tumor necrosis factor-alpha and nitric oxide. Leuk Res 1998; 22: 501–507
   PubMed Web of Science ®Google Scholar
• Roman V, Zhao H, Fourneau J M, Marconi A, Dugas N, Dugas B, Sigaux F, Kolb J P. Expression of a functional inducible nitric oxide synthase in hairy cell leukemia and ESKOL cell line. Leukemia 1999, In press
   PubMed Web of Science ®Google Scholar